| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1038440140 |
| P356 | DOI | 10.1186/1741-7015-9-5 |
| P932 | PMC publication ID | 3029216 |
| P698 | PubMed publication ID | 21235760 |
| P5875 | ResearchGate publication ID | 49756160 |
| P50 | author | Patrick Gérardin | Q55190792 |
| Gerard Breart | Q56380598 | ||
| Denis Malvy | Q28152059 | ||
| Alain Michault | Q29382419 | ||
| P2093 | author name string | Adrian Fianu | |
| Corinne Mussard | |||
| François Favier | |||
| Karim Boussaïd | |||
| Olivier Rollot | |||
| Bernard-Alex Gaüzere | |||
| P2860 | cites work | Two Chikungunya isolates from the outbreak of La Reunion (Indian Ocean) exhibit different patterns of infection in the mosquito, Aedes albopictus | Q21090106 |
| Characterization of reemerging chikungunya virus | Q21090531 | ||
| A single mutation in chikungunya virus affects vector specificity and epidemic potential | Q21131599 | ||
| A mouse model for Chikungunya: young age and inefficient type-I interferon signaling are risk factors for severe disease | Q21559504 | ||
| Post-epidemic Chikungunya disease on Reunion Island: course of rheumatic manifestations and associated factors over a 15-month period | Q21562272 | ||
| Human muscle satellite cells as targets of Chikungunya virus infection | Q21562321 | ||
| Chikungunya disease in nonhuman primates involves long-term viral persistence in macrophages | Q24288996 | ||
| Aedes albopictus, an arbovirus vector: From the darkness to the light | Q24289424 | ||
| Post-infective and chronic fatigue syndromes precipitated by viral and non-viral pathogens: prospective cohort study | Q24676579 | ||
| Amelioration of alphavirus-induced arthritis and myositis in a mouse model by treatment with bindarit, an inhibitor of monocyte chemotactic proteins | Q39818590 | ||
| Active infection of human blood monocytes by Chikungunya virus triggers an innate immune response | Q39881534 | ||
| Mucocutaneous features of Chikungunya fever: a study from an outbreak in West Bengal, India | Q40405494 | ||
| Atypical Chikungunya virus infections: clinical manifestations, mortality and risk factors for severe disease during the 2005-2006 outbreak on Réunion | Q40412307 | ||
| Cutaneous manifestations of chikungunya fever: observations made during a recent outbreak in south India | Q40429006 | ||
| Chikungunya virus induced sudden sensorineural hearing loss | Q40431263 | ||
| Production of pro-inflammatory cytokines correlates with the symptoms of acute sickness behaviour in humans. | Q40515386 | ||
| Aedes albopictus and Aedes aegypti at Ile de la Réunion | Q40693685 | ||
| Chikungunya viral arthropathy: a clinical description. | Q40862589 | ||
| Acute symptoms and sequelae of Ross River virus infection in South-Western Australia: a follow-up study | Q40991610 | ||
| Chikungunya virus aches and pains: an emerging challenge | Q41940293 | ||
| Rheumatoid arthritis after Chikungunya fever: a prospective follow-up study of 21 cases | Q44850643 | ||
| Persistent arthralgia associated with chikungunya virus: a study of 88 adult patients on reunion island | Q44851009 | ||
| Ocular involvement associated with an epidemic outbreak of chikungunya virus infection | Q44851284 | ||
| Chikungunya virus infection. A retrospective study of 107 cases | Q44851815 | ||
| Natural history of Ross River virus-induced epidemic polyarthritis. | Q45730612 | ||
| Prolonged arthritis associated with sindbis-related (Pogosta) virus infection | Q45739658 | ||
| Illness-specific catastrophic thinking and overperception in asthma. | Q50874282 | ||
| [Neurological manifestations in Chikungunya: about 23 cases collected in Reunion Island]. | Q52589569 | ||
| When are observational studies as credible as randomised trials? | Q80122032 | ||
| Twenty years of research on cytokine-induced sickness behavior | Q24684760 | ||
| Multidisciplinary Prospective Study of Mother-to-Child Chikungunya Virus Infections on the Island of La Réunion | Q27485485 | ||
| Connective tissue metabolism in chikungunya patients | Q27485701 | ||
| Estimating Chikungunya prevalence in La Réunion Island outbreak by serosurveys: Two methods for two critical times of the epidemic | Q27486800 | ||
| Impact of Chikungunya Virus Infection on Health Status and Quality of Life: A Retrospective Cohort Study | Q27490293 | ||
| Chronic pain associated with the Chikungunya Fever: long lasting burden of an acute illness | Q27491022 | ||
| Changing patterns of chikungunya virus: re-emergence of a zoonotic arbovirus | Q29620003 | ||
| Outbreak of chikungunya on Reunion Island: early clinical and laboratory features in 157 adult patients | Q33375141 | ||
| Neurological complications in Chikungunya fever. | Q34010040 | ||
| Serious acute chikungunya virus infection requiring intensive care during the Reunion Island outbreak in 2005-2006. | Q34013185 | ||
| Factors associated with persistence of arthralgia among Chikungunya virus-infected travellers: report of 42 French cases | Q34087571 | ||
| Clinical progression of chikungunya fever during acute and chronic arthritic stages and the changes in joint morphology as revealed by imaging | Q34099818 | ||
| Persistent chronic inflammation and infection by Chikungunya arthritogenic alphavirus in spite of a robust host immune response | Q34110965 | ||
| Rheumatoid arthritic syndrome after chikungunya fever | Q34224013 | ||
| Chikungunya infection: an emerging rheumatism among travelers returned from Indian Ocean islands. Report of 47 cases | Q34579545 | ||
| Macrophage-derived proinflammatory factors contribute to the development of arthritis and myositis after infection with an arthrogenic alphavirus | Q34773767 | ||
| Ross River virus disease in tropical Queensland: evolution of rheumatic manifestations in an inception cohort followed for six months. | Q34928639 | ||
| Estimating the burden of musculoskeletal disorders in the community: the comparative prevalence of symptoms at different anatomical sites, and the relation to social deprivation | Q35547574 | ||
| Sindbis viruses and other alphaviruses as cause of human arthritic disease | Q35956866 | ||
| Does cytokine-induced depression differ from idiopathic major depression in medically healthy individuals? | Q37392195 | ||
| Atypical manifestations of chikungunya infection | Q37588903 | ||
| Chikungunya virus takes centre stage in virally induced arthritis: possible cellular and molecular mechanisms to pathogenesis | Q37616326 | ||
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | chikungunya | Q243257 |
| Chikungunya virus | Q15794049 | ||
| population-based cohort study | Q108562148 | ||
| P5008 | on focus list of Wikimedia project | ScienceSource | Q55439927 |
| P304 | page(s) | 5 | |
| P577 | publication date | 2011-01-14 | |
| P1433 | published in | BMC Medicine | Q4835947 |
| P1476 | title | Perceived morbidity and community burden after a Chikungunya outbreak: the TELECHIK survey, a population-based cohort study | |
| P478 | volume | 9 |
| Q40288450 | A Role for RNA Viruses in the Pathogenesis of Burkitt's Lymphoma: The Need for Reappraisal |
| Q39034137 | Acquired auditory neuropathy spectrum disorder after an attack of chikungunya: case study |
| Q27027313 | Alphaviruses: population genetics and determinants of emergence |
| Q30240216 | Animal Models of Chikungunya Virus Infection and Disease. |
| Q34273343 | Arthritogenic alphaviruses--an overview |
| Q34264257 | Attenuation of Chikungunya virus vaccine strain 181/clone 25 is determined by two amino acid substitutions in the E2 envelope glycoprotein |
| Q58575620 | Cellular and Molecular Immune Response to Chikungunya Virus Infection |
| Q44843511 | Chikungunya Virus Disease among Travelers-United States, 2014-2016. |
| Q44843465 | Chikungunya Virus: Pathophysiology, Mechanism, and Modeling |
| Q27305283 | Chikungunya fever: a clinical and virological investigation of outpatients on Reunion Island, South-West Indian Ocean |
| Q38118022 | Chikungunya fever: epidemiology, clinical syndrome, pathogenesis and therapy |
| Q89857312 | Chikungunya outbreak in Bangladesh (2017): Clinical and hematological findings |
| Q33684369 | Chikungunya vaccine candidate is highly attenuated and protects nonhuman primates against telemetrically monitored disease following a single dose. |
| Q36582816 | Chikungunya virus and prospects for a vaccine |
| Q63246354 | Chikungunya virus infection in Indonesia: a systematic review and evolutionary analysis |
| Q30235512 | Chikungunya virus: epidemiology, replication, disease mechanisms, and prospective intervention strategies |
| Q35240173 | Chikungunya virus: evolution and genetic determinants of emergence |
| Q24701719 | Chikungunya: epidemiology |
| Q36828876 | Chronic chikungunya virus musculoskeletal disease: what are the underlying mechanisms? |
| Q37040562 | Development and Validation of a Quantitative, One-Step, Multiplex, Real-Time Reverse Transcriptase PCR Assay for Detection of Dengue and Chikungunya Viruses |
| Q31141844 | Development of a stable virus-like particle vaccine formulation against Chikungunya virus and investigation of the effects of polyanions |
| Q40170640 | Differences in response of primary human myoblasts to infection with recent epidemic strains of Chikungunya virus isolated from patients with and without myalgia |
| Q83227399 | Discrete viral E2 lysine residues and scavenger receptor MARCO are required for clearance of circulating alphaviruses |
| Q92021203 | Estimating the cost of illness and burden of disease associated with the 2014-2015 chikungunya outbreak in the U.S. Virgin Islands |
| Q29353555 | First Chikungunya Outbreak in Suriname; Clinical and Epidemiological Features |
| Q59353759 | Genetic control of alphavirus pathogenesis |
| Q38234431 | Global protein profiling studies of chikungunya virus infection identify different proteins but common biological processes |
| Q40301923 | High concentrations of circulating interleukin-6 and monocyte chemotactic protein-1 with low concentrations of interleukin-8 were associated with severe chikungunya fever during the 2009-2010 outbreak in Thailand |
| Q59354717 | Human CD8 T-cell activation in acute and chronic chikungunya infection |
| Q34000129 | Identification of initial severity determinants to predict arthritis after chikungunya infection in a cohort of French gendarmes |
| Q39382188 | Immunogenicity, safety, and tolerability of a recombinant measles-virus-based chikungunya vaccine: a randomised, double-blind, placebo-controlled, active-comparator, first-in-man trial |
| Q41929524 | Long-term Chikungunya Sequelae in Curaçao: Burden, Determinants, and a Novel Classification Tool |
| Q38659305 | MUTATIONS IN THE E2 GLYCOPROTEIN AND THE 3' UNTRANSLATED REGION ENHANCE CHIKUNGUNYA VIRUS VIRULENCE IN MICE. |
| Q33916134 | Neurocognitive outcome of children exposed to perinatal mother-to-child Chikungunya virus infection: the CHIMERE cohort study on Reunion Island |
| Q39148837 | Neurologic Manifestation of Chikungunya Virus |
| Q56448842 | Occurrence of Chronic Stage Chikungunya in the General Population of Martinique during the First 2014 Epidemic: A Prospective Epidemiological Study |
| Q40235356 | Osteoclastogenesis induced by CHIKV-infected fibroblast-like synoviocytes: a possible interplay between synoviocytes and monocytes/macrophages in CHIKV-induced arthralgia/arthritis |
| Q30407929 | Pandemic influenza due to pH1N1/2009 virus: estimation of infection burden in Reunion Island through a prospective serosurvey, austral winter 2009. |
| Q37214518 | Pathogenic Chikungunya Virus Evades B Cell Responses to Establish Persistence |
| Q28804036 | Persistent RNA virus infections: do PAMPS drive chronic disease? |
| Q40160164 | Persistent arthralgia and related risks factors in laboratory-confirmed cases of Chikungunya virus infection in Mexico |
| Q24288818 | Post-chikungunya chronic inflammatory rheumatism: results from a retrospective follow-up study of 283 adult and child cases in La Virginia, Risaralda, Colombia |
| Q21195256 | Predictors of Chikungunya rheumatism: a prognostic survey ancillary to the TELECHIK cohort study |
| Q38789052 | Prevalence of Post-Chikungunya Infection Chronic Inflammatory Arthritis: A Systematic Review and Meta-Analysis |
| Q40248768 | Prevalence of and risk factors for chronic arthralgia and rheumatoid-like polyarthritis more than 2 years after infection with chikungunya virus |
| Q35238179 | Recombinant modified vaccinia virus Ankara expressing glycoprotein E2 of Chikungunya virus protects AG129 mice against lethal challenge |
| Q55312161 | Rheumatism and chronic fatigue, the two facets of post-chikungunya disease: the TELECHIK cohort study on Reunion island. |
| Q57091906 | Seroprevalence and Symptomatic Attack Rate of Chikungunya Virus Infection, United States Virgin Islands, 2014-2015 |
| Q64892583 | Src Family Kinase Inhibitors Block Translation of Alphavirus Subgenomic mRNAs. |
| Q33853893 | Therapeutic administration of a recombinant human monoclonal antibody reduces the severity of chikungunya virus disease in rhesus macaques |
| Q33628488 | Understanding the evolution and spread of chikungunya virus in the Americas using complete genome sequences |
| Q26314670 | Vector competence of Aedes aegypti in transmitting Chikungunya virus: effects and implications of extrinsic incubation temperature on dissemination and infection rates |
| Q85472618 | [Chikungunya in children] |